R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

The rise and market race of anti-IL23p19 therapies in IBD: H...

The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two decades.

R&D

The UK can’t just be a life sciences lab – we need manufactu...

Rachel Reeves is right: the UK is at the forefront of life sciences, with some world-leading research and innovation.

R&D

Woman, microscope and scientist in research

Advances in manufacturing in vivo lentiviral vectors: Challe...

Lentiviral vectors (LVVs) have proven to be extremely versatile genetic delivery vehicles, gaining space as a gene transfer technology tool used both for cell and gene therapies.

R&D

Defining, building, and implementing the next wave of biopha...

In a new podcast, pharmaphorum speaks with two PharmaLex experts about navigating complex R&D processes to unleash the next wave of biopharma.

R&D

pharmaceutical construction isometric medical illustration

How pharmaceutical companies can speed up construction proje...

The pharmaceutical construction industry has seen explosive growth, a trend with substantial implications for healthcare industry, and global health outcomes.

R&D